Matinas Biopharma Holdings Inc. (NYSE AMERICAN: MTNB)
$0.7099
+0.0099 ( +10.75% ) 12.9K
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.